Total Payments
$18,321
2024 Payments
$137.45
Companies
7
Transactions
26
Medicare Patients
6,161
Medicare Billing
$418,236
Payment Breakdown by Category
Consulting$12,356 (67.4%)
Other$2,677 (14.6%)
Travel$2,414 (13.2%)
Food & Beverage$873.51 (4.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $12,356 | 4 | 67.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,677 | 2 | 14.6% |
| Travel and Lodging | $2,414 | 7 | 13.2% |
| Food and Beverage | $873.51 | 13 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $17,622 | 17 | $0 (2018) |
| Bigfoot Biomedical Inc | $245.68 | 2 | $0 (2022) |
| Novo Nordisk Inc | $125.00 | 1 | $0 (2017) |
| Phathom Pharmaceuticals, Inc. | $121.40 | 1 | $0 (2024) |
| Lilly USA, LLC | $90.06 | 2 | $0 (2019) |
| GENZYME CORPORATION | $90.00 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $26.90 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $137.45 | 2 | Phathom Pharmaceuticals, Inc. ($121.40) |
| 2022 | $124.99 | 1 | Bigfoot Biomedical Inc ($124.99) |
| 2021 | $120.69 | 1 | Bigfoot Biomedical Inc ($120.69) |
| 2019 | $190.91 | 4 | Lilly USA, LLC ($90.06) |
| 2018 | $2,599 | 2 | SANOFI-AVENTIS U.S. LLC ($2,599) |
| 2017 | $15,148 | 16 | SANOFI-AVENTIS U.S. LLC ($15,023) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $121.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/29/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Neuroscience | ||||||
| 03/22/2022 | Bigfoot Biomedical Inc | UNITY DIABETES MANAGEMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: DIABETES | ||||||
| 11/08/2021 | Bigfoot Biomedical Inc | UNITY DIABETES MANAGEMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $120.69 | General |
| Category: DIABETES | ||||||
| 04/27/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $74.43 | General |
| Category: Diabetes | ||||||
| 04/27/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Diabetes | ||||||
| 04/25/2019 | GENZYME CORPORATION | SOLIQUA 100/33 (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $90.00 | General |
| Category: DIABETES | ||||||
| 03/21/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: Neuroscience | ||||||
| 11/06/2018 | SANOFI-AVENTIS U.S. LLC | DIABETES - DISEASE (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| 09/30/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $2,587.20 | General |
| Category: DIABETES | ||||||
| 12/31/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Consulting Fee | In-kind items and services | $6,090.16 | General |
| Category: DIABETES | ||||||
| 09/27/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Consulting Fee | Cash or cash equivalent | $3,374.00 | General |
| Category: DIABETES | ||||||
| 09/27/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Travel and Lodging | In-kind items and services | $968.90 | General |
| Category: DIABETES | ||||||
| 09/27/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Travel and Lodging | In-kind items and services | $236.78 | General |
| Category: DIABETES | ||||||
| 09/27/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Travel and Lodging | In-kind items and services | $234.60 | General |
| Category: DIABETES | ||||||
| 09/27/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $108.75 | General |
| Category: DIABETES | ||||||
| 06/09/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Consulting Fee | Cash or cash equivalent | $723.00 | General |
| Category: DIABETES | ||||||
| 06/09/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $100.01 | General |
| Category: DIABETES | ||||||
| 03/23/2017 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 03/22/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Consulting Fee | Cash or cash equivalent | $2,169.00 | General |
| Category: DIABETES | ||||||
| 03/22/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Travel and Lodging | In-kind items and services | $444.60 | General |
| Category: DIABETES | ||||||
| 03/22/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Travel and Lodging | In-kind items and services | $273.27 | General |
| Category: DIABETES | ||||||
| 03/22/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Travel and Lodging | In-kind items and services | $239.40 | General |
| Category: DIABETES | ||||||
| 03/22/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: DIABETES | ||||||
| 03/22/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | Cash or cash equivalent | $17.70 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,104 | 1,497 | $271,450 | $75,896 |
| 2022 | 20 | 1,562 | 2,175 | $419,237 | $114,600 |
| 2021 | 21 | 1,687 | 2,622 | $539,754 | $124,768 |
| 2020 | 25 | 1,808 | 2,815 | $402,424 | $102,972 |
Total Patients
6,161
Total Services
9,109
Medicare Billing
$418,236
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 308 | 459 | $149,690 | $34,416 | 23.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 214 | 214 | $47,936 | $28,142 | 58.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 31 | $14,353 | $3,414 | 23.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 260 | 323 | $6,812 | $2,690 | 39.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 81 | 129 | $20,552 | $2,022 | 9.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 29 | $6,732 | $1,490 | 22.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 17 | 17 | $1,321 | $1,259 | 95.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 75 | $13,200 | $731.10 | 5.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $1,590 | $568.17 | 35.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 48 | 58 | $3,744 | $544.49 | 14.5% |
| 85610 | Blood test, clotting time | Office | 2023 | 58 | 105 | $4,254 | $441.00 | 10.4% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 14 | 15 | $480.00 | $102.41 | 21.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 16 | 24 | $786.00 | $74.64 | 9.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 362 | 606 | $188,163 | $46,834 | 24.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 243 | 243 | $50,127 | $32,394 | 64.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 43 | 43 | $27,925 | $11,956 | 42.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 38 | $16,114 | $4,560 | 28.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 106 | 187 | $29,064 | $2,799 | 9.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 39 | 39 | $3,374 | $2,740 | 81.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 50 | $10,940 | $2,513 | 23.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 22 | 22 | $44,568 | $2,299 | 5.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 42 | 42 | $3,150 | $1,267 | 40.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 42 | 42 | $3,150 | $1,266 | 40.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 316 | 397 | $7,136 | $1,169 | 16.4% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 27 | 27 | $1,080 | $1,078 | 99.8% |
About Dr. John Peng, MD
Dr. John Peng, MD is a Internal Medicine healthcare provider based in Lynnwood, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669485447.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Peng, MD has received a total of $18,321 in payments from pharmaceutical and medical device companies, with $137.45 received in 2024. These payments were reported across 26 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($12,356).
As a Medicare-enrolled provider, Peng has provided services to 6,161 Medicare beneficiaries, totaling 9,109 services with total Medicare billing of $418,236. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Lynnwood, WA
- Active Since 08/14/2006
- Last Updated 02/01/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1669485447
Products in Payments
- SOLIQUA (Drug) $17,610
- UNITY DIABETES MANAGEMENT SYSTEM (Device) $245.68
- Tresiba (Drug) $125.00
- VOQUEZNA (Drug) $121.40
- JARDIANCE (Drug) $90.06
- SOLIQUA 100/33 (Drug) $90.00
- INVEGA SUSTENNA (Drug) $26.90
- DIABETES - DISEASE (Drug) $11.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lynnwood
Dr. Su Yong Pak, M.d, M.D
Internal Medicine — Payments: $4,304
Internal Medicine $4,304
Dr. James Bowers, M.d, M.D
Internal Medicine — Payments: $555.87
Internal Medicine $555.87
Daniel Phan, M.d, M.D
Internal Medicine — Payments: $219.09
Internal Medicine $219.09
Chitra Manickam, Md, MD
Internal Medicine — Payments: $175.41
Internal Medicine $175.41
Dr. Joanne Chua, M.d, M.D
Internal Medicine — Payments: $26.98
Internal Medicine $26.98
Januario Estrada, M.d, M.D
Internal Medicine — Payments: $24.15
Internal Medicine $24.15